Quick Answer
IRADIMED CORP reported Net Income Loss of $22.48 million for the year ending 2025.
- IRADIMED CORP showed an increase of +16.9% in Net Income Loss from 2024 to 2025.
- This data is from IRADIMED CORP's annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), IRADIMED CORP's Net Income Loss has grown by 1,060.6%.
- Historical annual values: Fiscal year 2025: $22.48 million | Fiscal year 2024: $19.23 million | Fiscal year 2023: $17.19 million | Fiscal year 2022: $12.83 million | Fiscal year 2021: $9.33 million | Fiscal year 2020: $1.37 million | Fiscal year 2019: $9.63 million | Fiscal year 2018: $6.30 million | Fiscal year 2017: $499.8 thousand | Fiscal year 2016: $7.21 million | Fiscal year 2015: $7.53 million | Fiscal year 2014: $2.05 million | Fiscal year 2013: $1.94 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: